TY - JOUR
T1 - Development and Introduction of the Filariasis Test Strip
T2 - A New Diagnostic Test for the Global Program to Eliminate Lymphatic Filariasis
AU - Pantelias, Anastasia
AU - King, Jonathan D.
AU - Lammie, Patrick
AU - Weil, Gary J.
PY - 2022/5/11
Y1 - 2022/5/11
N2 - A key component to achieving the global goal of elimination of lymphatic filariasis (LF) is the availability of appropriate tools for disease mapping, monitoring, and surveillance. However, the development of these tools for a neglected disease such as LF can be a challenge. The lack of a commercial market and low familiarity with these diseases leave little incentive for diagnostic manufacturers to invest in this space. The Filarial Test Strip (FTS) development story provides a case study on how a multi-stakeholder, public-private partnership model facilitated the development, evaluation, and introduction of a new monitoring and surveillance tool for LF. This paper will reflect on the experience with the FTS and document the process from development of the target product profile to adoption and scale-up in country programs. Lessons learned from both the successes and challenges experienced during this process may help inform future efforts to develop and introduce new diagnostic or surveillance tools for neglected diseases.
AB - A key component to achieving the global goal of elimination of lymphatic filariasis (LF) is the availability of appropriate tools for disease mapping, monitoring, and surveillance. However, the development of these tools for a neglected disease such as LF can be a challenge. The lack of a commercial market and low familiarity with these diseases leave little incentive for diagnostic manufacturers to invest in this space. The Filarial Test Strip (FTS) development story provides a case study on how a multi-stakeholder, public-private partnership model facilitated the development, evaluation, and introduction of a new monitoring and surveillance tool for LF. This paper will reflect on the experience with the FTS and document the process from development of the target product profile to adoption and scale-up in country programs. Lessons learned from both the successes and challenges experienced during this process may help inform future efforts to develop and introduce new diagnostic or surveillance tools for neglected diseases.
UR - http://www.scopus.com/inward/record.url?scp=85144584341&partnerID=8YFLogxK
U2 - 10.4269/ajtmh.21-0990
DO - 10.4269/ajtmh.21-0990
M3 - Article
C2 - 35292584
AN - SCOPUS:85144584341
SN - 0002-9637
VL - 106
SP - 56
EP - 60
JO - The American journal of tropical medicine and hygiene
JF - The American journal of tropical medicine and hygiene
IS - 5
ER -